Bio Blast Pharma Ltd: Diferență între versiuni
The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Bio Blast Pharma Ltd listata cu simbolul US.ORPN ==Descriere companie== BioBlast Pharma (www.bioblastpharma.com) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on a...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Bio Blast Pharma Ltd listata cu simbolul US.ORPN | Pagina dedicata companiei Bio Blast [[PHARMA|Pharma]] Ltd listata cu simbolul US.ORPN | ||
==Descriere companie== | ==Descriere companie== | ||
BioBlast Pharma (www.bioblastpharma.com) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on a deep understanding of the disease-causing bi ological processes, and potentially offer solutions for several diseases that share the same biological pathology. BioBlast was founded in 2012 and is traded on the NASDAQ under the symbol "ORPN". | BioBlast Pharma (www.bioblastpharma.com) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on a deep understanding of the disease-causing bi ological processes, and potentially offer solutions for several diseases that share the same biological pathology. BioBlast was founded in 2012 and is traded on the [[Nasdaq|NASDAQ]] under the symbol "ORPN". | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||